Jornay PM - Evening-Dosed Methylphenidate for ADHD

Date: August 12, 2019
Issue #: 
1578Summary: 
The FDA has approvedJornay PM (Ironshore), a
capsule formulation of methylphenidate with a
delayed-release outer layer and an extended-release
inner layer, for once-nightly treatment of attention-deficit hyperactivity disorder (ADHD) in patients>6
years old.Jornay PM is the first methylphenidate
product to become available in the US that is taken
in the evening; other long-acting methylphenidate
formulations are taken in the morning. It is being
marketed specifically for patients who have disruptive
ADHD symptoms in the morning.

Source: The Medical Letter - July 24, 2019 Category: Drugs & Pharmacology Authors: admin Tags: Adhansia ADHD Aptensio Biphentin Concerta Contempla daytrana Dexmethylphenidate Focalin Foquest Jornay PM QuiliChew Quilivant Ritalin Source Type: research